ADMA Biologics Stock: From Plasma To Profits With A Pinch Of Prudence (NASDAQ:ADMA)

Health visitor and a woman during home

Phynart Studio/E+ via Getty Images


ADMA Biologics (NASDAQ:ADMA) is a commercial biopharmaceutical company that specializes in creating plasma-derived biologics for treating immunodeficient patients. Through its subsidiaries, ADMA BioManufacturing and ADMA BioCenters, the company produces and distributes FDA-approved products such as

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *